Harry Stylli

Founder at

Immunis.AI, Inc.

64 year

68 connections

Health Technology

Consumer Services

Health Services

Profile

Harry Stylli was the founder of Biora Therapeutics, Inc., founded in 2010, where the title held was Chairman & Chief Executive Officer from 2010 to 2021.
Dr. Stylli is also the founder of Immunis.
AI, Inc...
Current jobs include Executive Chairman at OncoCell MDx, Inc since 2019 and Director at Duke Institute For Brain Sciences.
Former jobs include President & Chief Executive Officer at Sequenom, Inc. from 2005 to 2009, President & Chief Executive Officer at Xencor, Inc. from 2004 to 2005, President & Chief Executive Officer at CovX Research LLC from 2002 to 2003, Director at Molecular Insight Pharmaceuticals, Inc. from 2004 to 2010, Director at Micropharma Ltd., President at Aurora Biosciences Corp.
from 1995 to 2002, and President at Pan Vera LLC in 1995.
Education includes a doctorate from the University of London, an MBA from The Open University, and an undergraduate degree from the University of East London.

Harry Stylli active positions

Companies	Position	Start
Duke Institute For Brain Sciences Duke Institute For Brain Sciences Miscellaneous Commercial ServicesCommercial Services The Duke Institute for Brain Sciences at Duke University is an interdisciplinary center dedicated to advancing neuroscience research, education, and community engagement. The private company is based in Durham. The institute promotes collaborative brain science across diverse disciplines and translates discoveries into health and societal solutions. It encompasses research themes such as brain health and wellness, cognition, neurotechnology, brain development and aging, cellular and molecular neuroscience, perception, emotions, social behavior, computation, hormones, immunology, movement, and intersections with art, humanities, law, policy, and business. The institute supports projects including high-resolution brain imaging, autism screening technologies, and studies on communication impairments following right-hemisphere strokes. Faculty conduct research on molecular mechanisms of social experience effects on the brain, adult neurogenic communication disorders post-stroke, and computational neuroscience. The institute provides resources for education, research collaboration, and public outreach, and offers opportunities for support and involvement.	Director/Board Member	-
OncoCell MDx, Inc OncoCell MDx, Inc BiotechnologyHealth Technology Engages in developing and commercializing immunogenic therapies	Chairman	01/04/2019
Immunis.AI, Inc. Immunis.AI, Inc. Packaged SoftwareTechnology Services Develops non-invasive blood-based immunogenomic platform	Founder	-

All active positions of Harry Stylli

Former positions of Harry Stylli

Companies	Position	End
BIORA THERAPEUTICS, INC.	Chief Executive Officer	01/09/2021
Molecular Insight Pharmaceuticals, Inc. Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes innovative molecular imaging pharmaceuticals	Director/Board Member	12/05/2010
SEQUENOM, INC.	Chief Executive Officer	28/09/2009
XENCOR, INC.	President	01/02/2005
CovX Research LLC CovX Research LLC BiotechnologyHealth Technology Manufactures biotherapeutics and medical products	President	01/07/2003

See the detail of Harry Stylli's experience

Training of Harry Stylli

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Harry Stylli's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Aurora Biosciences Corp. Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies	Health Technology
Sequenom, Inc. Sequenom, Inc. Medical/Nursing ServicesHealth Services Provides genomic and genetic analysis solutions	Health Services
Molecular Insight Pharmaceuticals, Inc. Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes innovative molecular imaging pharmaceuticals	Health Services
Xencor, Inc. Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions	Health Technology
Micropharma Ltd. Micropharma Ltd. Pharmaceuticals: MajorHealth Technology Formulates, manufactures & sells functional food, neutraceuticals and pharmaceutical products	Health Technology
Pan Vera LLC Pan Vera LLC BiotechnologyHealth Technology Develops protein drug targets and drug screening assays for high throughput screening	Health Technology
University of London University of London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Open University The Open University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CovX Research LLC CovX Research LLC BiotechnologyHealth Technology Manufactures biotherapeutics and medical products	Health Technology
University of East London University of East London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Biora Therapeutics, Inc. Biora Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing targeted therapies for cancer and autoimmune diseases	Health Technology
OncoCell MDx, Inc OncoCell MDx, Inc BiotechnologyHealth Technology Engages in developing and commercializing immunogenic therapies	Health Technology
Duke Institute For Brain Sciences Duke Institute For Brain Sciences Miscellaneous Commercial ServicesCommercial Services The Duke Institute for Brain Sciences at Duke University is an interdisciplinary center dedicated to advancing neuroscience research, education, and community engagement. The private company is based in Durham. The institute promotes collaborative brain science across diverse disciplines and translates discoveries into health and societal solutions. It encompasses research themes such as brain health and wellness, cognition, neurotechnology, brain development and aging, cellular and molecular neuroscience, perception, emotions, social behavior, computation, hormones, immunology, movement, and intersections with art, humanities, law, policy, and business. The institute supports projects including high-resolution brain imaging, autism screening technologies, and studies on communication impairments following right-hemisphere strokes. Faculty conduct research on molecular mechanisms of social experience effects on the brain, adult neurogenic communication disorders post-stroke, and computational neuroscience. The institute provides resources for education, research collaboration, and public outreach, and offers opportunities for support and involvement.	Commercial Services
Immunis.AI, Inc. Immunis.AI, Inc. Packaged SoftwareTechnology Services Develops non-invasive blood-based immunogenomic platform	Technology Services